Drug Profile
Tazarotene oral
Alternative Names: AGN 190168 oral; Oral tazarotene - Allergan; TazoralLatest Information Update: 19 May 2020
Price :
$50
*
At a glance
- Originator Allergan
- Class Antiacnes; Antipsoriatics; Esters; Keratolytics; Nicotinic acids; Pyrans; Pyridines; Retinoids
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne; Age-related macular degeneration; Cancer; Psoriasis
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 10 Jul 2007 Discontinued - Phase-I for Cancer in USA (PO)
- 10 Jul 2007 Discontinued - Phase-II for Acne in Europe (PO)